{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:49:39Z","timestamp":1791355779327,"version":"4.3.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate an interpretable machine learning\u2013based model for the early identification of the risk of clinical deterioration during hospitalization in newly diagnosed lung cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data of patients with newly diagnosed lung cancer admitted between July 2023 and December 2025 were retrospectively collected in this single-center study. A hybrid feature selection strategy integrating least absolute shrinkage and selection operator (LASSO) regression and the Boruta algorithm was employed to identify key predictors. Logistic regression (LR), random forest (RF), extreme gradient boosting (XGBoost), and support vector machine (SVM) models were constructed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC), calibration curves, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) values were further applied to interpret the model's decision-making process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,001 newly diagnosed lung cancer patients were included, comprising 121 patients (12.1%) in the deterioration group and 880 patients (87.9%) in the non-deterioration group. Through the hybrid feature selection approach, five core predictive variables were identified, including Activities of Daily Living (ADL) score, lymphocyte count, C-reactive protein (CRP), respiratory rate, and neutrophil count. Among the models, the SVM model achieved the highest observed AUC of 0.822 (95% CI: 0.737\u20130.899) in the internal validation set, with a sensitivity of 0.750 (95% CI: 0.594\u20130.893) and a specificity of 0.792 (95% CI: 0.740\u20130.838). After Platt scaling calibration, the model achieved a Brier score of 0.083 (Hosmer-Lemeshow\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.649), with a calibration intercept of 0.141 and a slope of 1.126, indicating satisfactory agreement between predicted and observed risks. DCA suggested a potential net clinical benefit. SHAP analysis, in conjunction with multivariable regression results, consistently demonstrated that ADL score and lymphocyte count were associated with reduced risk of clinical deterioration, whereas CRP and neutrophil count were associated with increased risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The SVM model developed in this study may help identify patients at risk of clinical deterioration among hospitalized lung cancer patients and may assist healthcare professionals in achieving early risk identification and potential clinical decision support.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1947529","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:36Z","timestamp":1791352296000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and internal validation of a predictive model for clinical deterioration in newly diagnosed lung cancer patients based on interpretable machine learning"],"prefix":"10.3389","volume":"13","author":[{"given":"Huiling","family":"Li","sequence":"first","affiliation":[{"name":"Department of Respiratory, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture","place":["Enshi City, Hu Bei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture","place":["Enshi City, Hu Bei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Department of Pulmonary and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture","place":["Enshi City, Hu Bei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanfang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"B3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/annonc\/mdu234","article-title":"Intensive care in patients with lung cancer: a multinational study","volume":"25","author":"Soares","year":"2014","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","article-title":"Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study","volume":"47","author":"Zampieri","year":"2021","journal-title":"Intensive Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/emermed-2020-210416","article-title":"Comparison of qSOFA and hospital early warning scores for prognosis in suspected sepsis in emergency department patients: a systematic review","volume":"39","author":"Sabir","year":"2022","journal-title":"Emerg Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"m1501","DOI":"10.1136\/bmj.m1501","article-title":"Early warning scores for detecting deterioration in adult hospital patients: systematic review and critical appraisal of methodology","volume":"369","author":"Gerry","year":"2020","journal-title":"BMJ (Clin Res Ed)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101919","DOI":"10.1016\/j.arr.2023.101919","article-title":"Repetitive transcranial magnetic stimulation combined with cognitive training for cognitive function and activities of daily living in patients with post-stroke cognitive impairment: a systematic review and meta-analysis","volume":"87","author":"Gao","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/jgs.15835","article-title":"Function, survival, and care utilization among older adults with hematologic malignancies","volume":"67","author":"DuMontier","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3390\/ijerph16142481","article-title":"The association between frailty and disability among the elderly in rural areas of Korea","volume":"16","author":"Choi","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","article-title":"Artificial intelligence in digital pathology\u2014new tools for diagnosis and precision oncology","volume":"16","author":"Bera","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13054-024-04935-x","article-title":"Machine learning derived serum creatinine trajectories in acute kidney injury in critically ill patients with sepsis","volume":"28","author":"Takkavatakarn","year":"2024","journal-title":"Crit Care (London, England)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1163.e1","DOI":"10.1016\/j.jamda.2016.09.010","article-title":"Frailty and the prediction of negative health outcomes: a meta-analysis","volume":"17","author":"Vermeiren","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12877-024-05173-0","article-title":"Screening for frailty and its association with activities of daily living, cognitive impairment, and falls among community-dwelling older adults in China","volume":"24","author":"Ji","year":"2024","journal-title":"BMC Geriatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12877-022-02902-1","article-title":"Kinematic analysis of activities of daily living performance in frail elderly","volume":"22","author":"Schmidle","year":"2022","journal-title":"BMC Geriatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ctrv.2017.10.006","article-title":"Disability in activities of daily living among adults with cancer: a systematic review and meta-analysis","volume":"61","author":"Neo","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jpainsymman.2020.10.012","article-title":"Disability in basic activities of daily living is associated with symptom burden in older people with advanced cancer or chronic obstructive pulmonary disease: a secondary data analysis","volume":"61","author":"Fettes","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","article-title":"Inflammation in cancer: therapeutic opportunities from new insights","volume":"24","author":"Xie","year":"2025","journal-title":"Mol Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-018-0010-y","article-title":"Inflammatory breast cancer biology: the tumour microenvironment is key","volume":"18","author":"Lim","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12916-022-02506-x","article-title":"C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis","volume":"20","author":"Zhu","year":"2022","journal-title":"BMC Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-025-02228-7","article-title":"Bidirectional role of neutrophils in tumor development","volume":"24","author":"Luyang","year":"2025","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaoncol.2019.1747","article-title":"Prognostic value of the lung immune prognostic index for patients treated for metastatic non-small cell lung cancer","volume":"5","author":"Kazandjian","year":"2019","journal-title":"JAMA Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcsm.12761","article-title":"Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study","volume":"12","author":"Zhang","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.clnu.2022.04.019","article-title":"Inflammatory burden as a prognostic biomarker for cancer","volume":"41","author":"Xie","year":"2022","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab","volume":"111","author":"Diem","year":"2017","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1947529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:36Z","timestamp":1791352296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1947529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":28,"alternative-id":["10.3389\/fmed.2026.1947529"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1947529","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1947529"}}